A diabetic father claims Ozempik left him to fight for his life with a blocked bowel. “Be very careful.”

Health

By: Andrew Court

The Oregon father of two believes Ozempik caused him to have two bowel obstructions that left him fighting for his life.

Wilson “Bo” Muhlheim, 79, told the Daily Mail that he was prescribed an injection late last year to help manage his type 2 diabetes.

Ozempic is approved by the US Food and Drug Administration for people with this condition; it has recently become very popular for weight loss.

It has also become controversial for its reported side effects. Most notably, the FDA’s Adverse Event Reporting System published 76 reports of deaths through September 30, 2018, involving products with semaglutide, the active ingredient in Ozempic and sister drug Wegovy.

Cases sent to FAERS are not medically confirmed. The Post has reached out to the FDA as well as Novo Nordisk, the Danish maker of Ozempic and Wegovy, for comment.

The drug mimics the natural hormone GLP-1, which slows the passage of food through the stomach and intestines, keeping people feeling fuller for longer.

Problems arise, however, if the medicine slows down the stomach too much or blocks the intestines.

Muhlheim is now warning Ozempic, encouraging potential users to think twice before filling a prescription.

“The amount of weight you can lose by taking this drug is negligible compared to the risks,” Mühlheim told the Daily Mail on Tuesday.

“People should be very careful,” he added. “This drug is not for anything like weight loss.”

Muehlheim, who is originally from Eugene, weighed 265 pounds when she was prescribed Ozempic to help regulate her blood sugar and shed unwanted pounds.

The diabetic father said he experienced no side effects after starting the weekly injections and dropped 14 pounds over the next six months.

But he claims he suffered severe stomach pains earlier this year and was taken to the emergency room, where doctors discovered he had a blocked bowel, just hours away from a potentially fatal rupture.

Muhlheim lacerated his stomach and eventually recovered from the incident.

Doctors reportedly did not blame Ozempik, but instead blamed Mühlheim’s colon twist.

He continued using Ozempic for another six months before another sudden blockage put him back in the hospital.

Mühlheim believes the diabetes medication is responsible for his medical episodes.

“We were all just guessing [the first blockage] had to do with my bowel movements without even looking at the other issues,” he explained. “But now they’ve gone back and looked at the imaging, the blockage point has nothing to do with those abnormalities in my bowel.”

“This leads one to believe that it is the same as the cause of and [Ozempic] it’s the only thing we can think of that causes it,” he declared.

Muhlheim says he stopped taking Ozempic and is slowly recovering from his second intestinal blockage.

He is not the first person to report serious problems after injecting the drug.

In September, the FDA announced that ileus (the medical term for intestinal obstruction) would be listed as a side effect on Ozempic’s label.

At the time, the agency said it had received 18 reports of people taking Ozempic suffering from the disease.

In the US, Novo Nordisk and Eli Lilly and Company, which make the popular diabetes drug Mounjaro, are suing over claims that the syringes can cause serious gastrointestinal problems such as gastroparesis or “stomach upset”. stroke’ which can lead to death.

The law firm Morgan & Morgan told The Post in August that it had received 500 similar allegations from clients in 45 states, as well as claims of injuries allegedly caused by other weight-loss drugs, including Rybelsus and Saxenda. from:

In Australia, Ozempik is accused of the death of a woman trying to lose weight for a wedding.